Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Not Confirmed
Not Confirmed
17-19 March, 2026
RNA Leaders EuropeRNA Leaders Europe
Not Confirmed
Not Confirmed
17-19 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Industry Trade Show
Not Confirmed
17-19 March, 2026
RNA Leaders EuropeRNA Leaders Europe
Industry Trade Show
Not Confirmed
17-19 March, 2026
Digital content

22 Apr 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/variant-pharmaceuticals-expands-development-focus-into-60-billion-anti-inflammatory-market-with-worldwide-license-to-novel-inflammasome-inhibitor-300835132.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE